en

PRODUCT DETAIL

Dovato 50 mg/300 mg filmom obalené tablety

Code 2098D
MA number EU/1/19/1370/002
Product Form: tbl flm 90 (3x30)x50 mg/300 mg (fľ.HDPE-multibal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR25 Lamivudine and dolutegravir
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 01.07.2019
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.04.2024
eu-flag.png sk-flag.png